Media News

SUZHOU, China, Aug. 9, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the first patient has been dosed in the phase II clinical study (KN046-209) of PD-L1/CTLA-4 bispecific antibody KN046 plus Axitinib for the first line treatment of advanced Non-Small Cell Lung Cancer (NSCLC). KN046-209 is an open-label, multi-center, Phase 2 study in subjects with treatment-naïve locally advanced...

Mean body weight loss of 9.6% and 9.0% in participants receiving 1.8 mg and 2.4 mg XW003 for 14 weeks, respectively Up to 72.4% of participants achieved weight loss of at least 5% at week 14 XW003 was safe and well tolerated with gastrointestinal side effects as the most commonly reported adverse events HANGZHOU, China...

FB2001 (Bofutrelvir) is a Coronavirus Mpro inhibitor, which exhibited potent anti-SARS-CoV-2 activity in vitro and in vivo Phase 1 results show FB2001 to be generally safe and well tolerated. No significant difference was observed between Chinese and American populations. Single-agent antiviral concentrations have been reached in the blood plasma and lung...

SHENZHEN, China, Aug. 8, 2022 /PRNewswire/ -- BGI has topped the Asia Pacific and China life science corporate institution ranking table for the seventh year running, released in the 2022 Nature Index Annual Tables. With a 19 percent increase in its adjusted share metric, BGI ranked eighth among global life science corporate institutions, which is an improvement over the preceding year's...

Ultrasound leaders from around the world will gather virtually to help define the latest innovations in point-of-care ultrasound ROCKVILLE, Md., Aug. 8, 2022 /PRNewswire/ -- The global point-of-care ultrasound (POCUS) community, consisting of numerous specialties of healthcare providers, will gather virtually to expand and share their knowledge and experience with ultrasound at POCUS World Conference 2022 on September...

BEIJING, Aug. 8, 2022 /PRNewswire/ -- WeTrade Group Inc. (NASDAQ: WETG), an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud intelligent systems for micro-businesses, completed an in-depth discussion of the strategic partnership with Jiqing Biomedical Technology Co. Ltd recently. The companies will sign the official contract soon and Wetrade will take the exclusive sale channel...

The Converge platform enables healthcare organizations to deliver better outcomes, improve operational efficiency, and achieve digital care delivery aspirations, benefiting patients and providers alike. SAN ANTONIO, Aug. 8, 2022 /PRNewswire/ -- Recently, Frost & Sullivan researched the virtual care delivery industry and, based on its analysis results, recognizes  Amwell® (NYSE: AMWL) with the 2022 North America Customer Value Leadership Award....

Vittorio Sebastiano, globally recognized for pioneering science, expands his role at company he co-founded as it moves closer to clinical research MOUNTAIN VIEW, Calif., Aug. 8, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that co-founder Vittorio Sebastiano, PhD, will become its head of research. ...

The Global Fund collaborates with the Johnson & Johnson Foundation and the Skoll Foundation to Launch the Africa Frontline First Catalytic Fund Private sector investments to the Global Fund's Africa Frontline First Catalytic Fund from the Johnson & Johnson Foundation and the Skoll Foundation totaling US$ 25 million. The Global...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142) announced that the preclinical results of porustobart (HBM4003, or the HCAb 4003-2 in the research paper), a next-generation fully human heavy-chain antibody with a Treg depletion mechanism, were published in the Proceedings of the National...